U.S. market Closed. Opens in 1 day 8 hours 58 minutes

CHRS | Coherus BioSciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue257.24M211.04M326.55M475.82M356.07M1.56M1.56M190.11M30.04M31.11M2.75M1.90M
Cost of Revenue162.78M70.08M57.59M37.67M17.08M3.23M160.53M254.44M212.68M78.22M31.28M34.89M
Gross Profit94.46M140.96M268.96M438.16M338.99M-1.68M-158.97M-64.33M-182.64M-47.12M-28.53M-32.99M
Operating Expenses301.45M397.84M532.82M281.84M231.22M204.42M233.69M306.04M249.11M95.79M38.74M40.42M
Selling, General & Admin185.62M198.48M169.71M139.08M137.04M94.18M71.30M51.60M36.05M17.56M7.46M5.53M
Research & Development109.44M199.36M363.11M142.76M94.19M110.24M162.39M254.44M213.06M78.22M31.28M34.89M
Other Operating ExpensesN/A3.82M-283.00K554.00K2.61M4.69M3.40M-3.88M-4.84M-18.59M-12.35M7.01M
Operating Income-203.20M-256.88M-263.86M156.32M107.77M-204.42M-232.14M-115.93M-219.07M-64.68M-35.99M-38.52M
Other Expenses / Income-35.07M-34.87M-23.24M-20.61M-14.99M-4.99M-6.15M-11.86M-4.87M-22.50M-17.64M5.50M
Before Tax Income-238.27M-291.75M-287.10M135.71M92.78M-209.41M-238.29M-127.79M-223.94M-87.18M-53.63M-33.02M
Income Tax Expenses-380.00K34.87M19.22M3.46M2.94M4.69M9.44M656.00K-7.35M-15.41M-7.06M8.53M
Net Income-237.89M-326.63M-306.32M132.24M89.83M-209.34M-238.17M-127.34M-223.26M-87.13M-53.63M-33.02M
Interest Expenses40.54M32.47M22.96M21.17M17.60M9.68M9.55M7.98M33.00K3.90M5.29M1.51M
Basic Shares Outstanding94.16M77.63M75.45M71.41M69.68M65.01M53.13M41.91M37.12M8.19M18.08M18.08M
Diluted Shares Outstanding94.16M77.63M75.45M83.49M73.19M65.03M53.13M41.91M37.12M8.19M18.08M18.08M
EBITDA-193.94M-255.58M-260.69M161.84M111.03M-204.42M-225.34M-116.81M-222.04M-82.72M-47.94M-31.28M
EBITDA Margin-75.39%-121.10%-79.83%34.01%31.18%-13,137.28%-14,481.75%-61.45%-739.11%-265.91%-1,742.57%-1,647.34%
EBIT-197.73M-259.28M-264.14M156.87M110.38M-194.96M-219.18M-118.70M-230.58M-98.65M-55.40M-22.98M
EBIT Margin-76.86%-122.86%-80.89%32.97%31.00%-12,529.82%-14,085.99%-62.44%-767.55%-317.13%-2,013.74%-1,209.90%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙